Prebiotic Treatment in People With Schizophrenia
University of Maryland, Baltimore
60 participants
Jan 25, 2023
INTERVENTIONAL
Conditions
Summary
The proposed project is based on the observation that schizophrenia is characterized by a chronic pro-inflammatory state, which contributes to the severity of a number of the clinical manifestations of the illness, including cognitive impairments, the treatment of which represents a critically important unmet therapeutic need.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prebiotin® is a fine, white to slightly yellow powder, which is mixed into water and has a slightly sweet taste.
Placebo prebiotic mixed into water
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05527210